AQST - Aquestive Therapeutics, Inc.

QQQ $ 612.14 $ 1.56 (0.26 %)

DIA $ 470.45 $ 1.64 (0.35 %)

SPY $ 672.31 $ 2.95 (0.44 %)

TLT $ 89.45 $ -0.19 (-0.21 %)

GLD $ 367.77 $ 0.35 (0.1 %)

Previous Close

$ 6.04

Open

$ 6.41

Bid

$ 5.77 x 380

Ask

$ 6.15 x 700

Day's Range

$ 5.79 - $ 6.41

52 Week Range

$ 2.12 - $ 7.55

Volume

2,822,282

Average Volume

Market Cap

736.9M

Beta (5Y Monthly)

$ 1.56

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-05-2025	09-30-2025	10-Q
2	08-11-2025	06-30-2025	10-Q
3	05-12-2025	03-31-2025	10-Q
4	03-05-2025	01-01-1970	10-K
5	11-04-2024	09-30-2024	10-Q
6	08-06-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	03-05-2024	12-31-2023	10-K
9	11-06-2023	09-30-2023	10-Q
10	08-07-2023	06-30-2023	10-Q
11	05-02-2023	03-31-2023	10-Q
12	03-31-2023	12-31-2022	10-K
13	11-01-2022	09-30-2022	10-Q
14	08-02-2022	06-30-2022	10-Q
15	05-04-2022	03-31-2022	10-Q
16	03-08-2022	12-31-2021	10-K
17	11-02-2021	09-30-2021	10-Q
18	08-03-2021	06-30-2021	10-Q
19	05-04-2021	03-31-2021	10-Q
20	03-09-2021	12-31-2020	10-K
21	11-04-2020	09-30-2020	10-Q
22	08-04-2020	06-30-2020	10-Q
23	05-05-2020	03-31-2020	10-Q
24	03-11-2020	12-31-2019	10-K
25	11-05-2019	09-30-2019	10-Q
26	08-06-2019	06-30-2019	10-Q
27	05-08-2019	03-31-2019	10-Q
28	03-14-2019	12-31-2018	10-K
29	11-06-2018	09-30-2018	10-Q
30	09-04-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Piper Sandler Maintains Overweight on Aque...
11/07/2025 12:54:04

Piper Sandler analyst David Amsellem maintains Aquestive Therapeutics (NASDAQ:AQST) with a Overweight and raises the price t...

Aquestive Therapeutics Affirms FY2025 Sale...
11/05/2025 21:02:42

Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

JMP Securities Maintains Market Outperform...
10/09/2025 11:35:07

JMP Securities analyst Jason Butler maintains Aquestive Therapeutics (NASDAQ:AQST) with a Market Outperform and raises the p...

Aquestive Secures New Patents for Needle-F...
10/08/2025 11:01:42

Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing m...

crinetics-pharmaceuticals-blackberry-perpetua-resources-and-other-big-stocks-moving-higher-on-friday

Crinetics Pharmaceuticals, BlackBerry, Per...
09/26/2025 14:23:15

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceutical...

ars-pharma-urges-fda-to-delay-approval-of-aquestives-allergic-reaction-treatment

ARS Pharma Urges FDA To Delay Approval Of ...
09/23/2025 16:01:54

ARS Pharmaceuticals petitioned the FDA to delay approval of Aquestive's epinephrine film, citing safety, dosing, and cardio...

12 Health Care Stocks Moving In Friday's I...
09/19/2025 17:06:19

coreweave-barrick-mining-fedex-and-other-big-stocks-moving-higher-on-friday

CoreWeave, Barrick Mining, FedEx And Other...
09/19/2025 14:31:28

Oppenheimer Maintains Outperform on Aquest...
09/08/2025 12:21:09

Oppenheimer analyst Francois Brisebois maintains Aquestive Therapeutics (NASDAQ:AQST) with a Outperform and raises the price...

12 Health Care Stocks Moving In Thursday's...
09/04/2025 17:05:59

shoe-carnival-american-eagle-ciena-victorias-secret-and-other-big-stocks-moving-higher-on-thursday

Shoe Carnival, American Eagle, Ciena, Vict...
09/04/2025 16:56:56

fda-confirms-direct-review-path-for-aquestives-allergy-treatment

FDA Confirms Direct Review Path For Aquest...
09/04/2025 16:44:41

Aquestive's Anaphylm could become the first oral epinephrine for severe allergic reactions after the FDA set a 2026 decisio...

12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

FDA Skips Advisory Committee Meeting For A...
09/04/2025 11:04:11

NDA remains on track for FDA PDUFA goal date of January 31, 2026Commercial planning continues enabling rapid launch following a...

10 Health Care Stocks Whale Activity In To...
08/14/2025 17:35:27

Aquestive Prices $85 Million Stock Offerin...
08/14/2025 10:30:40

Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing m...

Aquestive Secures $75M Funding Tied to FDA...
08/14/2025 10:05:57

Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing m...

Aquestive Therapeutics Affirms FY2025 Sale...
08/11/2025 20:02:39

Aquestive Therapeutics (NASDAQ:AQST) affirms FY2025 sales outlook from $44.000 million-$50.000 million to $44.000 million-$50.0...

Aquestive Therapeutics Q2 EPS $(0.14) Beat...
08/11/2025 20:02:17

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate o...